Epi CanaryEpi Canary
  • Home
  • Feed
  • Synthesis
  • Assessments
  • Scopes
  • Reliability
  • Sources
Epi Canary — Epidemic IntelligenceEvidence-led epidemic intelligence. Source-attributed evidence.
Arcede logoMade by Arcede

Public note

For situational awareness and research transparency. Not medical advice.

Novel Pathogen Detectionactive

Autochthonous dengue transmission will be confirmed in at least 2 Southern European countries during the July–October 2026 transmission season.

System-generated assessment. This assessment remains under review until the stated horizon or until sufficient evidence allows evaluation.

Moderate confidence

Confidence in this assessment
50%

The evidence is meaningful, but there is still material uncertainty. Based on 0 linked evidence items and assessed against Oct 31, 2026.

Assessed through Oct 31, 2026·0 linked evidence items·Tracking since Apr 13, 2026

02

How this assessment will be evaluated

The criteria the system uses to determine whether this assessment is borne out by the stated horizon.

Automated

Method

Evidence Match

The condition the system checks for when evaluating this assessment.

Minimum source quality

T1Primary Institutional

Evidence must meet or exceed this credibility tier to count toward evaluation.

Required terms

autochthonoustransmissionconfirmedcountries

03

Evidence quality mix

Tracking since Apr 13, 2026.

▸Integrity referencesCryptographic hashes for verification

Registration

06

Scope synthesis

The current analyst narrative for this scope.

Open synthesis →

Hong Kong confirms first locally acquired dengue case of 2026 vector season; multi-region simultaneous chikungunya escalation gaining strength with La Réunion, Spain, Mauritius, and Guangzhou epidemic modeling data.

07

Evidence linked to this assessment

0 linked items.

No linked evidence is available for this assessment yet.

Integrity anchor

Brier 0.202

19 resolved novel pathogen detection predictions.